Valon Lasers has crafted ophthalmic lasers for treatment of diabetic retinopathy, a major cause for blindness in developed countries
Valon Lasers main products, 532nm pattern scanning photocoagulators Valon 5G and Valon TT, are developed mainly for treatment of diabetic retinopathy – a major cause for blindness in developed countries if left untreated. The team behind Valon Lasers has crafted and developed innovative ophthalmic lasers since 1972. All the development and production work is crafted in Vantaa, Finland at Valon Lasers’ headquarters.
Inventure joined Valon Lasers in 2011.